Skip to main content
. 2023 Jan 31;59(2):273. doi: 10.3390/medicina59020273

Table 4.

Biomaterials and enzymatical/mechanical derived ADSC-SVF in vivo tendinopathy and tendon injury.

Authors Injury (Animal) Biomaterial Treatment ADSC-SVF Provenience Investigation Outcomes
Lipner et al. [64] Rotator Cuff tears (Sprague Dawley rats) Nanofibrous poly lactic co-glycolic acid scaffold Group 1: tendon suture
Group 2: tendon suture + acellular scaffold
Group 3: tendon suture + ADSC scaffold
Group 4: tendon suture + ADSC + BMP2 scaffold
Allogenic subcutaneous adipose tissue mice Histological, bone morphology, biomechanical outcomes The acellular scaffold showed a delayed healing response. Cellular + BMP2 scaffold showed decreased mechanical properties. No difference in bone morphology.
Chiou et al. [65] Achilles tendon midsubstance defect (Wistar rats) Tendon hydrogel scaffold Group 1: saline control
Group 2: tendon hydrogel
Group 3: tendon hydrogel scaffold + PRP
Group 4: tendon hydrogel scaffold + ADSC + PRP
Allogenic subcutaneous adipose tissue mice Histological, Biomechanical analysis Group 4 higher fibres organization. No biomechanical differences
Deng et al. [66] Achilles’tendon defect (new zeland rabbits) polyglycolic acid (PGA)+ PLA (polylactic acid) Group 1: scaffold
Group 2: scaffold + ADSC
Autologous, derived from nuchal side Gross view, Histological Biomechanical analysis Significant difference in mechanical strength in group 2, improved histological score.
Franklin et al. [67] Achilles’tendon defect and rotator cuff chronic tendinopahty
(Sprague Dawley rat)
Human decellularized flexor tendon hydrogel (tHG) Group 1: saline
Group 2: tHG
Group 3: tHG + ADSC
Group 4: tHg + FB
Group5
In commerce Flow citometry Enhance homing of adsc cells administred ev.